Report Details:
15 Companies Covered
95 Pages
Rising Breast Cancer Awareness and Technological Advancements to Drive the Global Mammography Market at a CAGR of 9.25% During the Forecast Period 2025 to 2035
Market Research Future (MRFR) has published a cooked research report on the “Global Mammography Market” that contains information from 2019 to 2035. The Mammography Market is estimated to register a CAGR of 9.25% during the forecast period of 2025 to 2035.
MRFR recognizes the following companies as the key players in the Global Mammography Market — GE Healthcare, Koninklijke Philips NV, Hologic, Inc., Gamma Medica, Inc., Konica Minolta Business Solutions India Private Limited, Carestream Health, BMI Biomedical International SRL, Canon Inc., FUJIFILM Holdings Corporation, GENERAL MEDICAL ITALIA, Siemens Healthcare, and Villa Systems Medical SpA.
Market Highlights
The Global Mammography Market is projected to grow from USD 2.98 billion in 2024 to USD 7.89 billion by 2035, registering a robust CAGR of 9.25% during the forecast period.
The growth of the mammography market is primarily driven by the rising incidence of breast cancer, increasing awareness regarding early detection, and technological advancements in imaging systems. According to the American Cancer Society, breast cancer remains the second leading cause of cancer-related deaths among women globally, with 2.26 million new cases and nearly 685,000 deaths recorded in 2020.
The growing demand for digital and 3D mammography systems, favorable government initiatives supporting early screening, and the integration of AI-driven imaging technologies are expected to propel market expansion. Campaigns such as the Kao Group Pink Ribbon Campaign in Japan and similar awareness programs across regions continue to encourage preventive screening practices.
Also, new technologies like 3D tomosynthesis, digital systems, and AI-powered diagnostic tools have made images more accurate and increased the number of early detections. This shows how important the mammography market is for diagnosing and treating breast cancer.
Segment Analysis
The Global Mammography Market has been segmented based on Type, Technology, Product, End User, and Region.
By Type:The market is segmented into Screening Mammography and Diagnostic Mammography. The Diagnostic Mammography segment held the largest market share in 2024, driven by rising demand for advanced diagnostic tools and increased breast cancer prevalence. However, the Screening Mammography segment is anticipated to grow fastest during the forecast period owing to increasing awareness and government-supported screening programs.
By Technology:Segments include 2D Technology, 3D Technology, and Combination Technology. The 3D Technology segment dominated the market, accounting for over 70% of total revenue, due to superior imaging accuracy and improved detection rates. Meanwhile, Combination Technology is projected to grow fastest as it offers enhanced contrast, dynamic range, and diagnostic precision.
By Product:Segments include Digital Systems, Analog Systems, Breast Tomosynthesis, and Film Screen Systems. The Breast Tomosynthesis segment held the largest market share in 2024, attributed to its capability to produce 3D breast images for better lesion detection. However, Digital Systems are expected to witness the highest growth rate due to their advanced imaging capabilities and increased adoption in diagnostic centers.
By End User:The market is segmented into Hospitals, Specialty Clinics, Research Institutes, Diagnostic Centers, and Others. Diagnostic Centers accounted for the largest revenue share, driven by the rising prevalence of screening facilities and accessibility to imaging technologies. The Hospital segment is expected to grow fastest, supported by integrated diagnostic services and increasing healthcare investments.
Regional Analysis
By region, the Global Mammography Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World.
North America:North America dominated the global market in 2024, supported by high healthcare spending, advanced infrastructure, and increased adoption of AI-based imaging solutions. The U.S. leads the region, driven by strong R&D investments and favorable reimbursement policies for breast cancer screening.
Europe:Europe accounted for the second-largest market share, driven by the availability of advanced mammography systems and growing awareness of early diagnosis. Germany held the largest share, while the UK emerged as the fastest-growing market in the region.
Asia-Pacific:The Asia-Pacific market is expected to grow at the fastest CAGR during the forecast period. The growth is fueled by expanding healthcare infrastructure, increasing government initiatives for breast cancer awareness, and rising disposable incomes in China, Japan, and India.
Rest of the World:The Middle East, Africa, and South America are showing steady growth due to increased healthcare access, the establishment of regional screening programs, and investments in diagnostic technologies.
Key Developments
- In October 2021, FUJIFILM Canada Inc. received Health Canada approval for its ASPIRE Cristalle digital mammography system, expanding its reach across Canadian provinces in partnership with Christie Innomed.
- In December 2020, Hologic Inc. received U.S. FDA approval for its Genius AI Detection software, a deep learning-based technology that aids radiologists in identifying potential cancers in breast tomosynthesis images.
Key Findings of the Study
- The Global Mammography Market is expected to reach USD 7.89 billion by 2035, at a CAGR of 9.25% during the forecast period.
- North America accounted for the largest market share in 2024.
- Based on Technology, the 3D Mammography segment held the largest market share in 2024.
- Based on End User, Diagnostic Centers accounted for the largest revenue share in 2024.
- Key market players include GE Healthcare, Koninklijke Philips NV, Hologic, Inc., Gamma Medica, Konica Minolta Business Solutions India Private Limited, Carestream Health, Canon Inc., FUJIFILM Holdings Corporation, Siemens Healthcare, and Villa Systems Medical SpA.
Related Reports
https://www.marketresearchfuture.com/reports/mammography-market-2443
